Valuation: OneSource Specialty Pharma Limited

Market Cap 191B 2B 1.75B 1.61B 1.5B 2.84B 2.88B 19.3B 7.51B 93.59B 7.51B 7.34B 324B P/E 2026
-229x
P/E 2027 * 46.1x
Enterprise Value 201B 2.11B 1.85B 1.7B 1.58B 3B 3.04B 20.4B 7.94B 98.9B 7.93B 7.76B 343B EV / Sales 2026
12.7x
EV / Sales 2027 * 8.95x
Free-Float
61.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.35%
1 week+4.03%
Current month+0.93%
1 month-7.07%
3 months+18.11%
6 months-7.51%
Current year-8.15%
1 week 1,630
Extreme 1630
1,740
1 month 1,530.3
Extreme 1530.3
1,800.2
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
2,088
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-29
Director of Finance/CFO - 2024-07-03
Compliance Officer - 2023-03-13
Director TitleAgeSince
Director/Board Member 65 2021-04-06
Director/Board Member 54 2024-02-29
Director/Board Member 66 2025-02-26
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%+4.03%-17.73% - 2.01B
+1.08%+7.56%+3.61%+9.84% 49.92B
+0.40%-1.37%+401.69%+625.15% 40.23B
-0.52%+6.57%+25.41%-5.37% 34.55B
+3.97%+6.71%+26.06%+63.36% 33.09B
-4.19%-1.84%+3.76%+32.17% 27.51B
-2.40%+1.60% - - 17.05B
+1.34%+5.68%+75.77%+141.51% 15.92B
-0.95%+0.76%+12.92%+21.59% 13.86B
+1.69%+3.09%+93.44%+99.19% 13.52B
Average +0.01%+4.55%+69.44%+123.43% 24.77B
Weighted average by Cap. +0.23%+4.51%+90.18%+141.43%

Financials

2026 2027 *
Net sales 13.41B 141M 123M 113M 105M 200M 203M 1.36B 528M 6.58B 528M 517M 22.83B 22.3B 234M 205M 189M 175M 332M 337M 2.26B 879M 10.95B 878M 859M 37.96B
Net income -1.19B -12.48M -10.93M -10.07M -9.34M -17.74M -17.98M -120M -46.89M -584M -46.86M -45.83M -2.03B 4.13B 43.33M 37.95M 34.96M 32.45M 61.61M 62.45M 418M 163M 2.03B 163M 159M 7.03B
Net Debt 10.81B 113M 99.22M 91.39M 84.83M 161M 163M 1.09B 426M 5.3B 425M 416M 18.39B 8.86B 92.84M 81.31M 74.89M 69.52M 132M 134M 896M 349M 4.35B 349M 341M 15.07B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
26-07-06 ₹1,663.10 -0.35% 93,521
26-07-03 ₹1,669.00 -1.10% 352,191
26-07-02 ₹1,687.60 +2.27% 156,722
26-07-01 ₹1,650.10 +0.14% 90,119
26-06-30 ₹1,647.80 +3.07% 130,578
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,663.10INR
Average target price
2,036.75INR
Spread / Average Target
+22.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock